Suppr超能文献

人高密度脂蛋白肝脏受体的特性研究

Characterization of a human hepatic receptor for high density lipoproteins.

作者信息

Hoeg J M, Demosky S J, Edge S B, Gregg R E, Osborne J C, Brewer H B

出版信息

Arteriosclerosis. 1985 May-Jun;5(3):228-37. doi: 10.1161/01.atv.5.3.228.

Abstract

Characterization of the membrane receptor for the low density lipoproteins (LDL) has led to insights into cellular receptor physiology as well as mammalian lipid transport. Result with LDL have stimulated the search for specific receptors for other plasma lipoproteins. Receptors for high density lipoproteins (HDL) have been identified in human fibroblasts and smooth muscle cells. Specificity for this receptor has been difficult to define since normal HDL contains several apolipoproteins, and particles containing apolipoproteins B and E have been shown to compete for HDL binding. In the present study, we demonstrate that HDL isolated from a patient devoid of apolipoprotein E was bound specifically by human hepatic membranes. This binding reached saturation within 2 hours and was EDTA-resistant. Assuming a single receptor model, we found that 2.9 x 10(15) receptors/mg membrane protein bound with an affinity KD = 3.5 x 10(-7) M at 0 to 4 degrees C and KD = 1.9 x 10(-7) M at 37 degrees C. The binding was effectively competed with intact HDL3, with HDL3 that had undergone selective arginine and lysine residue modification, and with antibodies to apolipoproteins A-I and A-II. However, LDL, asialofetuin, and HDL3 which had undergone tyrosine modification by nitration, and anti-apolipoprotein B did not compete with apo A-I HDL binding. In contrast to LDL binding, the human hepatoma cell line, HEPG2, increased HDL binding with cholesterol loading that was specific for HDL3. Thus, hepatic tissue can modulate its recognition of HDL. Finally, hepatic membranes from a patient lacking normal hepatic LDL receptors bound apo A-I HDL normally. These data indicate that a saturable, specific regulatable receptor for apo E-free HDL is present in human liver.

摘要

低密度脂蛋白(LDL)膜受体的特性研究为细胞受体生理学以及哺乳动物脂质转运提供了深入见解。LDL的研究结果激发了人们对其他血浆脂蛋白特异性受体的探索。高密度脂蛋白(HDL)受体已在人成纤维细胞和平滑肌细胞中被鉴定出来。由于正常HDL含有多种载脂蛋白,且已证明含有载脂蛋白B和E的颗粒会竞争HDL结合,因此该受体的特异性难以确定。在本研究中,我们证明从一名缺乏载脂蛋白E的患者中分离出的HDL与人肝细胞膜特异性结合。这种结合在2小时内达到饱和,且对EDTA具有抗性。假设为单一受体模型,我们发现每毫克膜蛋白有2.9×10¹⁵个受体在0至4℃时以亲和力KD = 3.5×10⁻⁷M结合,在37℃时KD = 1.9×10⁻⁷M。完整的HDL3、经过精氨酸和赖氨酸残基选择性修饰的HDL3以及抗载脂蛋白A-I和A-II的抗体可有效竞争这种结合。然而,LDL、去唾液酸胎球蛋白、经硝化酪氨酸修饰的HDL3以及抗载脂蛋白B不能竞争载脂蛋白A-I HDL的结合。与LDL结合不同,人肝癌细胞系HEPG2随着胆固醇负载增加HDL结合,且这种增加对HDL3具有特异性。因此,肝组织可以调节其对HDL的识别。最后,一名缺乏正常肝LDL受体的患者的肝细胞膜正常结合载脂蛋白A-I HDL。这些数据表明人肝脏中存在一种可饱和、特异性且可调节的无载脂蛋白E HDL受体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验